Thursday, 15 October, 2:00-3:00 CEST
The ACCESS (vACcine Covid-19 monitoring readinESS) project is conducting preliminary research to identify data sources and methods that can be used in future research to monitor the safety and efficacy of COVID-19 vaccines. Commissioned by EMA, ACCESS is being performed under a tender composed of several university and other research teams, including RTI Health Solutions (RTI-HS) under the leadership of Utrecht University.
- Hospital case-based safety studies - Alison Kawai, ScD, Senior Research Epidemiologist with RTI-HS, will be presenting on a protocol template currently under development for a multisite hospital-based self-controlled study to assess specific adverse events following COVID-19 vaccines in Europe.
- Rapid assessment and safety evaluation studies using EHR data (UMCU)
- Prospective cohort event monitoring using apps (LAREB)
Please join us. Seats are limited.
Learn more about the ACCESS project here.